Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.

Thrombosis and haemostasis - 1 Mar 2005

Dargaud Yesim, Béguin Suzette, Lienhart Anne, Al Dieri Raed, Trzeciak Christine, Bordet Jean Claude, Hemker H Coenraad, Negrier Claude

Abstract excerpt

In haemophilia patients, a relationship is usually observed between the clinical expression of the disease and plasmatic factor VIII/factor IX (FVIII/FIX) activity. However, it is known from clinical experience, that some haemophilia patients, despite similar FVIII/FIX plasma levels, could exhibi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Factor IX
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemophilia A

Share to Hemophilia B

Share to Hemorrhage

Share to Kinetics

Share to Thrombin

Source

Identifiers

PMID: 15735797
DOI: 10.1160/TH04-10-0706

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-15735797-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.PMID 15735797Read ↗

Thrombin generation testing in haemophilia comprehensive care centres.Semantic proximity Read ↗

Thrombin generation and phenotypic correlation in haemophilia A.Semantic proximity Read ↗

The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A.Semantic proximity Read ↗

Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.Semantic proximity Read ↗

Thrombin generation and bleeding in haemophilia A.Semantic proximity Read ↗

Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.Semantic proximity Read ↗

Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype.Semantic proximity Read ↗

Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation.Semantic proximity Read ↗

Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.Semantic proximity Read ↗

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.Semantic proximity Read ↗

Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A.Semantic proximity Read ↗

Thrombin generation testing in routine clinical practice: are we there yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.